There are literally thousands of companies in that small-cap value quadrant that you should be concentrating on, none of which can possibly be described as "the next Microsoft." They might not carry the wallop of a potential Microsoft over the short term, but over many decades, and taken as a group ... wow.
Drugmaker Growth Without the FDA
ReplyDeletehttp://www.fool.com/investing/high-growth/2007/08/14/drug-maker-growth-without-the-fda.aspx